查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1700150

2032 年睡眠辅助市场预测：按产品、睡眠障碍、治疗方法、分销管道、最终用户和地区进行的全球分析

Sleep Aids Market Forecasts to 2032 - Global Analysis By Product (Mattresses & Pillows, Sleep Laboratories, Medications and Other Products), Sleep Disorder, Therapeutic Treatment, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球睡眠辅助市场预计在 2025 年达到 691.7 亿美元，到 2032 年将达到 1,183.8 亿美元，预测期内的复合年增长率为 7.98%。

帮助您入睡、保持睡眠或改善睡眠的药物、处方药或家用药物称为助眠剂。这些包括处方笺药、草药补充剂、非处方药和褪黑激素类产品。安眠药通常用于治疗因压力、时差或不规律的睡眠週期引起的暂时性睡眠障碍。有些具有调节人体睡眠-觉醒週期的功能，而有些则具有放鬆神经系统的功能。

睡眠障碍增多

由于睡眠卫生不良、久坐的生活方式和压力，失眠、睡眠呼吸中止症和不安腿症候群等疾病的发生率正在上升。随着知识的增加，越来越多的人正在寻求非医疗和医疗方法来改善睡眠品质。这导致对床、睡眠辅助器、睡眠监测设备等的需求增加。此外，越来越多的医疗保健专业人士推荐睡眠辅助产品，进一步推动了市场扩张。因此，睡眠辅助市场正在迅速扩大，以满足对有效睡眠辅助日益增长的需求。

安眠药的副作用和依赖性

由于头晕、白天嗜睡和认知障碍等诸多症状，安眠药的吸引力降低。过度使用通常会导致耐受性，这意味着需要服用更大剂量才能达到相同的效果。这增加了上瘾和戒断症状的可能性。随着对这些风险的认识不断提高，患者和医疗保健专业人员开始转向非药物治疗替代方案。结果，消费者对处方笺助眠剂的信心正在下降，阻碍了市场成长。

对非药物和天然解决方案的需求不断增长

由于担心成瘾性和不良副作用，消费者越来越多地寻求比传统药物更安全、更全面的替代品。这种转变导致了草药补充剂、冥想应用程式和失眠认知行为疗法（CBT-I）的流行。注重健康的人们开始转向天然助眠剂，如精油、缬草根和褪黑激素。此外，由于鼓励改善睡眠卫生和改变生活方式的健康趋势，市场也在成长。随着越来越多的人意识到恢復性睡眠的重要性，对这些安全、持久的治疗方法的需求只会增加。

严格的法律规范和产品召回

监管机构制定的严格的安全性和有效性要求使得新公司难以推出尖端产品。这些规定也限制了一些用于助眠的常见化学物质的供应。因安全问题而频繁引发的产品召回事件损害了消费者的信任和品牌声誉。召回还会导致供应链中断和财务损失。这些因素综合起来将阻碍对睡眠辅助产品开发的投资，进而减缓市场成长。

COVID-19的影响

COVID-19 疫情对睡眠辅助市场产生了重大影响，由于压力、焦虑和日常生活的干扰增加，导致需求增加。居家隔离和健康问题引发了普遍的睡眠障碍，导致消费者转向非处方睡眠解决方案、草药补充剂和睡眠技术设备。远端保健的扩展也使得处方笺睡眠辅助剂更容易取得。虽然供应链中断最初影响了产品的可得性，但疫情期间和疫情后人们对睡眠健康和心理健康意识的提高推动了整体市场的成长。

药物治疗领域预计将成为预测期内最大的领域

由于药物治疗能够有效缓解失眠和其他睡眠障碍患者的症状，预计在预测期内将占据最大的市场占有率。压力水平、焦虑和心理健康问题的不断上升导致对处方和非处方安眠药的需求增加。药品创新以及更安全、非成瘾性药物的引入进一步推动了市场的成长。易于获得和医生的推荐也是消费者对该药物偏好的原因。此外，老化社会更容易出现睡眠障碍，这也导致药物消费增加，刺激了整个市场的扩张。

预计睡眠诊所部门在预测期内将实现最高的复合年增长率。

预计睡眠诊所部门将在预测期内见证最高的成长率。这是为了为睡眠障碍提供准确的诊断和个人化治疗。这些诊所提高了人们对失眠、睡眠呼吸中止症和不安腿症候群等疾病的认识，推动了对治疗设备和药物的需求。随着全球睡眠障碍病例的增加，越来越多的患者透过这些专科中心寻求专家的帮助。此外，睡眠诊所正在推动先进监测和诊断技术的使用，从而刺激市场创新。

占比最大的地区：

在预测期内，由于压力水平和睡眠呼吸中止症的增加，预计亚太地区将占据最大的市场占有率。人们对心理健康的认识不断提高、生活方式不断改变以及老年人口不断增长，推动了对床垫、枕头、睡眠呼吸中止症设备和非处方药等睡眠辅助产品的需求。中国、印度和日本等国家由于其医疗基础设施不断扩大和可支配收入不断增加而成为主要贡献者。睡眠监测设备的技术进步也推动了市场的发展，亚太地区已成为睡眠辅助解决方案的主要新兴中心。

复合年增长率最高的地区：

预计在预测期内，北美地区将因压力相关疾病而呈现最高的复合年增长率。人们对优质睡眠重要性的认识不断提高，以及药品、床垫、睡眠实验室和穿戴式装置等各种产品的普及，促进了市场的扩张。技术进步和医疗保健支出的增加进一步推动了成长。美国凭藉较高的诊断率和先进的医疗保健基础设施在该地区处于领先地位。消费者对非处方药和自然睡眠解决方案的偏好也在影响市场趋势。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球助眠产品市场

  • 床垫和枕头
  • 睡眠研究实验室
  • 製药
  • 睡眠呼吸中止症治疗设备
  • 穿戴式睡眠追踪器
  • 智慧床和睡眠监测设备
  • 其他产品

6. 全球睡眠辅助产品市场（依睡眠障碍）

  • 失眠
  • 睡眠呼吸中止症
  • 不宁腿（RLS）
  • 嗜睡症
  • 梦游
  • 磨牙
  • 其他睡眠障碍

7. 全球助眠产品市场（按治疗方法）

  • 药物治疗
  • 认知行为治疗（CBT）
  • 光疗法
  • 睡眠卫生教育
  • 其他治疗方法

8. 全球助眠产品市场（依分销管道）

  • 零售药局
  • 医院药房
  • 网路药局
  • 睡眠诊所
  • 超级市场
  • 其他分销管道

9. 全球助眠产品市场（依最终用户划分）

  • 医院
  • 居家照护
  • 睡眠诊所
  • 个人
  • 其他最终用户

9. 全球助眠产品市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Koninklijke Philips NV
  • ResMed Inc.
  • Sanofi SA
  • Merck & Co., Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc（GSK）
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Cadwell Industries, Inc.
  • Medtronic plc
  • Compumedics Limited
  • Natus Medical Incorporated
  • SomnoMed Ltd.
  • Fisher & Paykel Healthcare Corporation Limited
  • Drive DeVilbiss Healthcare
  • Sleep Number Corporation
  • Serta Simmons Bedding, LLC
  • Zydus Lifesciences Ltd.
Product Code: SMRC29053

According to Stratistics MRC, the Global Sleep Aids Market is accounted for $69.17 billion in 2025 and is expected to reach $118.38 billion by 2032 growing at a CAGR of 7.98% during the forecast period. Drugs, prescription drugs, or home remedies that help people fall asleep, stay asleep, or get better sleep are known as sleep aids. These consist of prescription pharmaceuticals, herbal supplements, over-the-counter medications and items based on melatonin. Sleep aids are frequently used to treat temporary sleep difficulties brought on by stress, jet lag, or inconsistent sleep cycles. Some function by regulating the body's sleep-wake cycle, while others relax the neurological system.

Market Dynamics:

Driver:

Rising prevalence of sleep disorders

Poor sleep hygiene, sedentary lifestyles, and stress are contributing to the rise in conditions like insomnia, sleep apnoea, and restless legs syndrome. As knowledge increases, more people are looking for both non-medical and medical ways to enhance the quality of their sleep. The demand for goods like beds, sleep aids, and sleep monitoring equipment has increased as a result. Additionally, more healthcare professionals are recommending sleep aids, which is driving the market's expansion. As a result, the market for sleep aids is increasing quickly to satisfy the rising need for efficient sleep aids.

Restraint:

Side effects and dependence on sleep medications

The allure of these medications is diminished by the numerous complaints of dizziness, daytime sleepiness, and cognitive impairments. Overuse frequently results in tolerance, necessitating greater dosages to achieve the same results. This raises the possibility of addiction and the symptoms of withdrawal. Patients and healthcare professionals are increasingly using non-pharmacological alternatives as awareness of these hazards increases. As a result, consumer confidence in prescription sleep aids is eroding, which is impeding market growth.

Opportunity:

Growth in demand for non-pharmacological and natural solutions

A growing number of consumers are looking for safer, more holistic alternatives to conventional pharmaceuticals because they are worried about dependency and negative effects. As a result of this change, herbal supplements, meditation applications, and cognitive behavioural treatment for insomnia (CBT-I) have become increasingly popular. Health-conscious people are increasingly using natural sleep aids including essential oils, valerian root, and melatonin. Furthermore, the market is expanding due to wellness trends that encourage improved sleep hygiene and lifestyle changes. The need for these safe and long-lasting remedies is only increasing as people realise how important restorative sleep is.

Threat:

Stringent regulatory framework and product recalls

Strict safety and efficacy requirements set by regulatory agencies make it difficult for new companies to introduce cutting-edge goods. The availability of some common chemicals used in sleep aids is likewise restricted by these rules. Consumer confidence and brand reputation are harmed by frequent product recalls brought on by safety concerns. Recalls also cause supply chain disruptions and monetary losses. When combined, these factors deter investment in sleep aid developments and slow down market growth.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the sleep aids market, leading to increased demand due to heightened stress, anxiety, and disrupted daily routines. Lockdowns and health concerns triggered widespread sleep disturbances, pushing consumers to seek over-the-counter sleep solutions, herbal supplements, and sleep tech devices. Telehealth expansion also facilitated easier access to prescription sleep aids. While supply chain disruptions initially affected product availability, the overall market witnessed growth as awareness of sleep health and mental well-being gained importance during and after the pandemic.

The medications segment is expected to be the largest during the forecast period

The medications segment is expected to account for the largest market share during the forecast period, due to effective relief for individuals suffering from insomnia and other sleep disorders. Rising stress levels, anxiety, and mental health issues have led to increased demand for prescription and over-the-counter sleep medications. Pharmaceutical innovations and the introduction of safer, non-habit-forming drugs further boost market growth. The ease of availability and physician recommendations also drive consumer preference toward medications. Additionally, the aging population, prone to sleep disturbances, contributes to higher medication consumption, fueling overall market expansion.

The sleep clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the sleep clinics segment is predicted to witness the highest growth rate, due to by providing accurate diagnosis and personalized treatment for sleep disorders. These clinics increase awareness about conditions like insomnia, sleep apnea, and restless leg syndrome, boosting demand for therapeutic devices and medications. With rising cases of sleep disorders globally, more patients are seeking professional help through these specialized facilities. Sleep clinics also promote the use of advanced monitoring and diagnostic technologies, fueling innovation in the market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increased stress levels and sleep apnea. Greater awareness about mental health, changing lifestyles, and growing elderly populations are fueling demand for sleep aid products such as mattresses, pillows, sleep apnea devices, and OTC medications. Countries like China, India, and Japan are key contributors, with expanding healthcare infrastructure and rising disposable incomes. Technological advancements in sleep monitoring devices also boost the market, making Asia Pacific a major emerging hub for sleep aid solutions.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to stress-related disorders. Increasing awareness about the importance of quality sleep and the availability of a wide range of products such as medications, mattresses, sleep labs, and wearables contribute to market expansion. Technological advancements and growing healthcare spending further support growth. The U.S. leads the region due to high diagnosis rates and advanced healthcare infrastructure. Consumer preference for non-prescription and natural sleep solutions is also shaping market trends.

Key players in the market

Some of the key players profiled in the Sleep Aids Market include Koninklijke Philips N.V., ResMed Inc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc (GSK), Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Cadwell Industries, Inc., Medtronic plc, Compumedics Limited, Natus Medical Incorporated, SomnoMed Ltd., Fisher & Paykel Healthcare Corporation Limited, Drive DeVilbiss Healthcare, Sleep Number Corporation, Serta Simmons Bedding, LLC and Zydus Lifesciences Ltd.

Key Developments:

In February 2024, ResMed extended its collaboration with EnsoData, a provider of AI-driven sleep scoring software. This partnership enables more efficient diagnosis and treatment of sleep disorders through machine learning and digital health platforms.

In August 2023, Philips expanded its manufacturing capabilities in India to include a broader range of Personal Health products. The company enhanced production at its co-manufacturing site in Baddi, Himachal Pradesh, to produce mother and childcare products alongside existing beauty and grooming items.

In July 2023, ResMed acquired Somnoware, a U.S.-based sleep and respiratory care diagnostics software company. The move strengthens ResMed's digital health ecosystem and enhances its support for physicians in managing patients with sleep apnea and other respiratory conditions.

Products Covered:

  • Mattresses & Pillows
  • Sleep Laboratories
  • Medications
  • Sleep Apnea Devices
  • Wearable Sleep Trackers
  • Smart Beds & Sleep Monitoring Devices
  • Other Products

Sleep Disorders Covered:

  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome (RLS)
  • Narcolepsy
  • Sleepwalking
  • Bruxism
  • Other Sleep Disorders

Therapeutic Treatments Covered:

  • Pharmacological Treatment
  • Cognitive Behavioral Therapy (CBT)
  • Light Therapy
  • Sleep Hygiene Education

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Sleep Clinics
  • Supermarkets
  • Other Distribution Channels

End Users Covered:

  • Hospitals
  • Homecare Settings
  • Sleep Clinics
  • Individuals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Sleep Aids Market, By Product

  • 5.1 Introduction
  • 5.2 Mattresses & Pillows
  • 5.3 Sleep Laboratories
  • 5.4 Medications
  • 5.5 Sleep Apnea Devices
  • 5.6 Wearable Sleep Trackers
  • 5.7 Smart Beds & Sleep Monitoring Devices
  • 5.8 Other Products

6 Global Sleep Aids Market, By Sleep Disorder

  • 6.1 Introduction
  • 6.2 Insomnia
  • 6.3 Sleep Apnea
  • 6.4 Restless Legs Syndrome (RLS)
  • 6.5 Narcolepsy
  • 6.6 Sleepwalking
  • 6.7 Bruxism
  • 6.8 Other Sleep Disorders

7 Global Sleep Aids Market, By Therapeutic Treatment

  • 7.1 Introduction
  • 7.2 Pharmacological Treatment
  • 7.3 Cognitive Behavioral Therapy (CBT)
  • 7.4 Light Therapy
  • 7.5 Sleep Hygiene Education
  • 7.6 Other Therapeutic Treatments

8 Global Sleep Aids Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail Pharmacies
  • 8.3 Hospital Pharmacies
  • 8.4 Online Pharmacies
  • 8.5 Sleep Clinics
  • 8.6 Supermarkets
  • 8.7 Other Distribution Channels

9 Global Sleep Aids Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Homecare Settings
  • 9.4 Sleep Clinics
  • 9.5 Individuals
  • 9.6 Other End Users

9 Global Sleep Aids Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Koninklijke Philips N.V.
  • 11.2 ResMed Inc.
  • 11.3 Sanofi S.A.
  • 11.4 Merck & Co., Inc.
  • 11.5 Pfizer Inc.
  • 11.6 GlaxoSmithKline plc (GSK)
  • 11.7 Teva Pharmaceutical Industries Ltd.
  • 11.8 Takeda Pharmaceutical Company Limited
  • 11.9 Cadwell Industries, Inc.
  • 11.10 Medtronic plc
  • 11.11 Compumedics Limited
  • 11.12 Natus Medical Incorporated
  • 11.13 SomnoMed Ltd.
  • 11.14 Fisher & Paykel Healthcare Corporation Limited
  • 11.15 Drive DeVilbiss Healthcare
  • 11.16 Sleep Number Corporation
  • 11.17 Serta Simmons Bedding, LLC
  • 11.18 Zydus Lifesciences Ltd.

List of Tables

  • Table 1 Global Sleep Aids Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Sleep Aids Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Sleep Aids Market Outlook, By Mattresses & Pillows (2024-2032) ($MN)
  • Table 4 Global Sleep Aids Market Outlook, By Sleep Laboratories (2024-2032) ($MN)
  • Table 5 Global Sleep Aids Market Outlook, By Medications (2024-2032) ($MN)
  • Table 6 Global Sleep Aids Market Outlook, By Sleep Apnea Devices (2024-2032) ($MN)
  • Table 7 Global Sleep Aids Market Outlook, By Wearable Sleep Trackers (2024-2032) ($MN)
  • Table 8 Global Sleep Aids Market Outlook, By Smart Beds & Sleep Monitoring Devices (2024-2032) ($MN)
  • Table 9 Global Sleep Aids Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 10 Global Sleep Aids Market Outlook, By Sleep Disorder (2024-2032) ($MN)
  • Table 11 Global Sleep Aids Market Outlook, By Insomnia (2024-2032) ($MN)
  • Table 12 Global Sleep Aids Market Outlook, By Sleep Apnea (2024-2032) ($MN)
  • Table 13 Global Sleep Aids Market Outlook, By Restless Legs Syndrome (RLS) (2024-2032) ($MN)
  • Table 14 Global Sleep Aids Market Outlook, By Narcolepsy (2024-2032) ($MN)
  • Table 15 Global Sleep Aids Market Outlook, By Sleepwalking (2024-2032) ($MN)
  • Table 16 Global Sleep Aids Market Outlook, By Bruxism (2024-2032) ($MN)
  • Table 17 Global Sleep Aids Market Outlook, By Other Sleep Disorders (2024-2032) ($MN)
  • Table 18 Global Sleep Aids Market Outlook, By Therapeutic Treatment (2024-2032) ($MN)
  • Table 19 Global Sleep Aids Market Outlook, By Pharmacological Treatment (2024-2032) ($MN)
  • Table 20 Global Sleep Aids Market Outlook, By Cognitive Behavioral Therapy (CBT) (2024-2032) ($MN)
  • Table 21 Global Sleep Aids Market Outlook, By Light Therapy (2024-2032) ($MN)
  • Table 22 Global Sleep Aids Market Outlook, By Sleep Hygiene Education (2024-2032) ($MN)
  • Table 23 Global Sleep Aids Market Outlook, By Other Therapeutic Treatments (2024-2032) ($MN)
  • Table 24 Global Sleep Aids Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 25 Global Sleep Aids Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 26 Global Sleep Aids Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 27 Global Sleep Aids Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 28 Global Sleep Aids Market Outlook, By Sleep Clinics (2024-2032) ($MN)
  • Table 29 Global Sleep Aids Market Outlook, By Supermarkets (2024-2032) ($MN)
  • Table 30 Global Sleep Aids Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 31 Global Sleep Aids Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Sleep Aids Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 33 Global Sleep Aids Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 34 Global Sleep Aids Market Outlook, By Sleep Clinics (2024-2032) ($MN)
  • Table 35 Global Sleep Aids Market Outlook, By Individuals (2024-2032) ($MN)
  • Table 36 Global Sleep Aids Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.